. | . |
Dormant viruses reactivate during spaceflight by Staff Writers Washington DC (SPX) Mar 19, 2019
Herpes viruses reactivate in more than half of crew aboard Space Shuttle and International Space Station missions, according to NASA research published in Frontiers in Microbiology. While only a small proportion develop symptoms, virus reactivation rates increase with spaceflight duration and could present a significant health risk on missions to Mars and beyond. NASA's rapid viral detection systems and ongoing treatment research are beginning to safeguard astronauts - and immunocompromised patients on Earth, too.
Herpes viruses reactivate in immunocompromised astronauts To study the physiological impact of spaceflight, Mehta and colleagues analyze saliva, blood and urine samples collected from astronauts before, during and after spaceflight. "During spaceflight there is a rise in secretion of stress hormones like cortisol and adrenaline, which are known to suppress the immune system. In keeping with this, we find that astronaut's immune cells - particularly those that normally suppress and eliminate viruses - become less effective during spaceflight and sometimes for up to 60 days after." In the midst of this stress-induced amnesty on viral killing, dormant viruses reactivate and resurface. "To date, 47 out of 89 (53%) astronauts on short space shuttle flights, and 14 out of 23 (61%) on longer ISS missions shed herpes viruses in their saliva or urine samples," reports Mehta. "These frequencies - as well as the quantity - of viral shedding are markedly higher than in samples from before or after flight, or from matched healthy controls." Overall, four of the eight known human herpes viruses were detected. These include the varieties responsible for oral and genital herpes (HSV), chickenpox and shingles (VZV) - which remain lifelong in our nerve cells - as well as CMV and EBV, which take permanent but uneventful residence in our immune cells during childhood. CMV and EBV, are two viruses associated with causing different strains of mononucleosis or the "kissing disease".
Deep-space exploration could depend on effective prevention and treatment However, continued virus shedding post flight could endanger immunocompromised or uninfected contacts on Earth, like newborns. "Infectious VZV and CMV were shed in body fluids up to 30 days following return from the International Space Station." What's more, as we prepare for human deep-space missions beyond the moon and Mars, the risk that herpes virus reactivation poses to astronauts and their contacts could become more crucial. "The magnitude, frequency and duration of viral shedding all increase with length of spaceflight." Developing countermeasures to viral reactivation is essential to the success of these deep-space missions, argues Mehta. "The ideal countermeasure is vaccination for astronauts - but this is so far available only against VZV." "Trials of other herpes virus vaccines show little promise, so our present focus is on developing targeted treatment regimens for individuals suffering the consequences of viral reactivation. "This research has tremendous clinical relevance for patients on Earth too. Already, our spaceflight-developed technologies for rapid viral detection in saliva have been employed in clinics and hospitals around the world."
China's finds microgravity promotes iPS cells regenerative potential Beijing (XNA) Mar 12, 2019 Research findings from China's Tianzhou-1 Space Mission have shown that the microgravity environment in space promotes heart cell differentiation of mice induced pluripotent stem (iPS) cells, providing new perspectives on future human space travel. During space travel, the human body is in a state of weightlessness due to minimal gravitational pull from the earth, which is known as microgravity. Exposure to microgravity may have a profound influence on the physiological function of human cells. ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |